What if building powerful, data-driven workflows no longer required juggling multiple tools or worrying about connectivity issues? With the introduction of native data tables, n8n has redefined what’s ...

Claude AI can now create and edit documents and other files. The feature could compromise your sensitive data. Monitor each interaction with the AI for suspicious behavior. Most popular generative AI ...

Microsoft is stripping editing features from its 365 Copilot app on iOS, forcing users to rely on standalone Word, Excel, and PowerPoint apps starting September 15, 2025. The 365 Copilot app for ...

Adobe Photoshop is among the most recognizable pieces of software ever created, used by more than 90% of the world's creative professionals, according to Photutorial. Built on the 20-billion-parameter ...

In the race to develop artificial intelligence, tech giants are building data centers that guzzle up water. That has led to problems for people who live nearby. In the race to develop artificial ...

Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 Congress on June 12, Editas Medicine, Inc. (NASDAQ:EDIT) revealed new in vivo ...

These latest results follow findings from the Heart-1 trial of VERVE-101, an earlier iteration of the therapy that the company paused testing for in April 2024, after a study participant developed ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

The original version of this story appeared in Quanta Magazine. Sometime in the fall of 2021, Andrew Krapivin, an undergraduate at Rutgers University, encountered a paper that would change his life.

The Cambridge-based base editing company, Beam Therapeutics, has announced initial safety and efficacy data from its Phase I/II trial of BEAM-302, establishing clinical proof-of-concept as a potential ...